Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | COVID-19 | Research

Usage of Natural Health Products (NHPs) for respiratory diseases: user characteristics and NHP-Consumption behavior during the Covid-19 pandemic in Germany

Authors: Miriam Wolf, Agnes Emberger-Klein, Klaus Menrad

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Background

Respiratory diseases (RD) can challenge healthcare systems around the globe. Natural health products (NHPs) are popular complementary and alternative medicine options for health issues concerning non-fatal RD. Little is known about the characteristics of the users of RD-NHPs and about their NHP consumption behavior during the Covid-19 pandemic in Germany.

Methods

A representative online survey was conducted in Germany in 2022. 1707 participants were classified based on having used NHPs for RD within the previous 12 months, having used NHPs but not for RD within the previous 12 months and not having used NHPs. Data were analyzed using descriptive and inferential statistical methods as well as a multinomial logistic regression model.

Results

Users of RD-NHPs within the previous 12 months were more likely to be employed and to consult pharmacists more often for non-fatal health issues than individuals who did not take RD-NHPs. RD-NHP users were more likely to suffer from a Covid-19 infection and to have children living in the same household than other NHP users. Compared to non-NHP users, RD-NHP users were more likely to be female, highly educated and have stronger openness-to-change value orientations. Vaccination-related behavior was no indicator of RD-NHP usage. Most RD-NHP users took NHPs in self-medication. Few reported informing their practitioner about their self-medication. Drugstores were the most visited supply source for NHPs during the pandemic, followed by pharmacies. Common information sources regarding NHPs were the products themselves and pharmacists.

Conclusion

This study emphasized the important role of NHPs as a popular prevention and treatment option for RD. RD-NHPs were more likely used by individuals who were employed, who suffered from a RD and who consult pharmacists for non-fatal health issues. The importance of product information and pharmacies as information sources should be considered to make communication strategies about safe self-medication options with RD-NHPs more effective, which could help to reduce the burden of health facilities regarding non-fatal RD. To improve and develop future pandemic-control strategies, health professionals and policy makers should consider NHP usage behavior and provide critical information about chances and risks of self-medicated NHP consumption.
Appendix
Available only for authorised users
Literature
1.
Zavalishina SY, Bakulina ED, Eremin MV, Kumantsova ES, Dorontsev AV, Petina ES. Functional changes in the human body in the model of acute respiratory infection. J Biochem Technol. 2021;12(1):22–6.
2.
Incze M, Grady D, Gupta A. I have a Cold—What do I need to know? JAMA Intern Med. 2018;178(9):1288.PubMed
3.
Jin X, Ren J, Li R, Gao Y, Zhang H, Li J et al. Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. eClinicalMedicine. 2021;37.
4.
Witek TJ, Ramsey DL, Carr AN, Riker DK. The natural history of community-acquired common colds symptoms assessed over 4-years. Rhinology. 2015;53(1):81–8.PubMed
5.
Schlipphak A, Wegner B, Wetzstein A, Wetzstein A, Wegner B, Schlipphak A. Krankheitsbedingte Fehlzeiten in der Bundesverwaltung und wie psychische Belastung und Gesundheitsfaktoren ermittelt werden können. Fehlzeiten-Report 2022: Verantwortung und Gesundheit: Springer; 2022. p. 601 – 14.
6.
7.
Lavine JS, Bjornstad ON, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science. 2021;371(6530):741–5.PubMedPubMedCentral
8.
Rosales-Mendoza S. Will plant-made biopharmaceuticals play a role in the fight against COVID-19? Expert opinion on biological therapy. 2020;20(6):545–8.
9.
Ali S, Alam M, Khatoon F, Fatima U, Elasbali AM, Adnan M, et al. Natural products can be used in therapeutic management of COVID-19: probable mechanistic insights. Biomed Pharmacother. 2022;147:112658.PubMedPubMedCentral
10.
Pan S-Y, Zhou S-F, Gao S-H, Yu Z-L, Zhang S-F, Tang M-K et al. New perspectives on how to discover drugs from herbal medicines: CAM’s outstanding contribution to modern therapeutics. Evidence-Based Complementary and Alternative Medicine. 2013;2013.
11.
Canada HMtQiRo. Natural Health Products Regulations: Canada Gazette; 2003 18.06.2003.
12.
Thakkar S, Anklam E, Xu A, Ulberth F, Li J, Li B, et al. Regulatory landscape of dietary supplements and herbal medicines from a global perspective. Regul Toxicol Pharmacol. 2020;114:104647.PubMed
13.
Knöss W, Stolte F, Reh K. Europäische Gesetzgebung zu besonderen Therapierichtungen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2008;51(7):771–8.PubMed
14.
BAH BdAeV. Der Arzneimittelmarkt in Deutschland. Zahlen und Fakten. Bonn, Berlin; 2021.
15.
Ganesan A. The impact of natural products upon modern drug discovery. Curr Opin Chem Biol. 2008;12(3):306–17.PubMed
16.
Welz AN, Emberger-Klein A, Menrad K. The importance of herbal medicine use in the german health-care system: prevalence, usage pattern, and influencing factors. BMC Health Serv Res. 2019;19(1):1–11.
17.
Wegener T, Nieber K, Kraft K, Siegmund S, Kelber O, Jobst D, et al. Versorgungsforschung mit pflanzlichen arzneimitteln–die pharmako-epidemiologische Datenbank PhytoVIS. Z für Phytotherapie. 2021;42(03):127–35.
18.
Afzal S, Ahmad HI, Jabbar A, Tolba MM, AbouZid S, Irm N et al. Use of medicinal plants for respiratory diseases in Bahawalpur, Pakistan. BioMed Research International. 2021;2021.
19.
Duțu LE, Popescu ML, Purdel CN, Ilie EI, Luță E-A, Costea L, et al. Traditional medicinal plants—a possible source of antibacterial activity on respiratory diseases induced by chlamydia pneumoniae, haemophilus influenzae, klebsiella pneumoniae and moraxella catarrhalis. Diversity. 2022;14(2):145.
20.
Oriola AO, Oyedeji AO. Plant-derived natural products as lead agents against Common Respiratory Diseases. Molecules. 2022;27(10):3054.PubMedPubMedCentral
21.
Komolafe K, Komolafe TR, Fatoki TH, Akinmoladun AC, Brai BI, Olaleye MT, et al. Coronavirus disease 2019 and herbal therapy: pertinent issues relating to toxicity and standardization of phytopharmaceuticals. Revista Brasileira de Farmacognosia. 2021;31(2):142–61.PubMedPubMedCentral
22.
Ng JY, Garber A, Luong M, Cooley K, Busse JW. No improvement in disclosure of natural health product use to primary care medical doctors in the last 15 years: a survey of naturopathic patients. Complement Ther Clin Pract. 2020;39:101106.PubMed
23.
BAH BdAeV. Der Arzneimittelmarkt in Deutschland. Zahlen und Fakten. 2019.
24.
Rajamma RK, Paswan AK, Pelton LE. Flipping the script: consumers’ propensity for self-medication. J Mark Theory Pract. 2021;29(4):448–62.
25.
Chautrakarn S, Khumros W, Phutrakool P. Self-Medication with Over-the-counter Medicines among the Working Age Population in Metropolitan Areas of Thailand. Front Pharmacol. 2021;12.
26.
Walji R, Boon H, Barnes J, Austin Z, Welsh S, Baker GR. Consumers of natural health products: natural-born pharmacovigilantes? BMC Complement Altern Med. 2010;10(1):8.PubMedPubMedCentral
27.
Tsui T, Boon H, Boecker A, Kachan N, Krahn M. Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approach. BMC Complement Altern Med. 2012;12:198.PubMedPubMedCentral
28.
Ji L-J, Lappas CM, Wang X-q, Meier BP. The Naturalness Bias Influences Drug and Vaccine decisions across cultures. Med Decis Making. 2022:0272989X221140803.
29.
Noone J, Blanchette CM. The value of self-medication: summary of existing evidence. J Med Econ. 2018;21(2):201–11.PubMed
30.
Zheng Z, Feng Z, Zhang D, Sun X, Dong D, Luo Y et al. Does self-medication reduce medical expenditure among the middle-aged and elderly population? A four-wave longitudinal study in China. Front Public Health. 2023;10.
31.
BAH BdAeV. Selbstmedikation - Ein wertvoller Beitrag für den Menschen und für unser Gesundheitssystem. 2022.
32.
Paudyal V, Sun S, Hussain R, Abutaleb MH, Hedima EW. Complementary and alternative medicines use in COVID-19: a global perspective on practice, policy and research. Res Social Administrative Pharm. 2022;18(3):2524–8.
33.
Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J. 2012;12(1):45–56.PubMedPubMedCentral
34.
Härtel U, Volger E. Inanspruchnahme und Akzeptanz klassischer Naturheilverfahren und alternativer heilmethoden in Deutschland–Ergebnisse einer repräsentativen Bevölkerungsstudie. Complement Med Res. 2004;11(6):327–34.
35.
Kemppainen LM, Kemppainen TT, Reippainen JA, Salmenniemi ST, Vuolanto PH. Use of complementary and alternative medicine in Europe: Health-related and sociodemographic determinants. Scand J Public Health. 2018;46(4):448–55.PubMed
36.
Attwell K, Ward PR, Meyer SB, Rokkas PJ, Leask J. Do-it-yourself: vaccine rejection and complementary and alternative medicine (CAM). Soc Sci Med. 2018;196:106–14.PubMed
37.
Zuzak TJ, Zuzak-Siegrist I, Rist L, Simoes-Wüst A. Attitudes towards vaccination: users of complementary and alternative medicine versus non-users. Swiss Med Wkly. 2008;138(4748):713–117.PubMed
38.
Bryden GM, Browne M, Rockloff M, Unsworth C. Anti-vaccination and pro-CAM attitudes both reflect magical beliefs about health. Vaccine. 2018;36(9):1227–34.PubMed
39.
Thomson P, Jones J, Browne M, Leslie SJ. Psychosocial factors that predict why people use complementary and alternative medicine and continue with its use: a population based study. Complement Ther Clin Pract. 2014;20(4):302–10.PubMed
40.
Drumond N. Future perspectives for patient-centric pharmaceutical drug product design with regard to solid oral dosage forms. J Pharm Innov. 2020;15(3):318–24.
41.
Menditto E, Orlando V, De Rosa G, Minghetti P, Musazzi UM, Cahir C, et al. Patient centric pharmaceutical drug product design—the impact on medication adherence. Pharmaceutics. 2020;12(1):44.PubMedPubMedCentral
42.
Schwartz SH. A repository of Schwartz Value Scales with instructions and an introduction. Online Readings in Psychology and Culture. 2021;2(2):9.
43.
Schwartz SH. An overview of the Schwartz theory of basic values. Online Readings in Psychology and Culture. 2012;2(1):2307–09191116.
44.
Chen X, Gao H, Zou Y, Lin F. Changes in psychological wellbeing, attitude and information-seeking behaviour among people at the epicentre of the COVID-19 pandemic: a panel survey of residents in Hubei province. China Epidemiol Infect. 2020;148:e201.PubMed
45.
Manganello J, Bleakley A, Schumacher P. Pandemics and PSAs: rapidly changing information in a New Media Landscape. Health Commun. 2020;35(14):1711–4.PubMed
46.
Panyod S, Ho C-T, Sheen L-Y. Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective. J Traditional Complement Med. 2020;10(4):420–7.
47.
Welz AN, Emberger-Klein A, Menrad K. Why people use herbal medicine: insights from a focus-group study in Germany. BMC Complement Altern Med. 2018;18(1):1–9.
48.
Soleymani S, Naghizadeh A, Karimi M, Zarei A, Mardi R, Kordafshari G, et al. COVID-19: General strategies for herbal therapies. J Evidence-Based Integr Med. 2022;27:2515690X211053641.
49.
Schendera CF. Datenqualität mit SPSS. Oldenbourg Verlag; 2011.
50.
Arya R, Antonisamy B, Kumar S. Sample size estimation in prevalence studies. Indian J Pediatr. 2012;79:1482–8.PubMed
51.
Lindeman M, Verkasalo M. Measuring values with the short Schwartz’s value survey. J Pers Assess. 2005;85(2):170–8.PubMed
52.
Wolf M, Bayerl T, Strobel P, Huber V, Emberger-Klein A, Buchner J et al. Neuartige Hopfenextrakte für die Neuroregeneration. TUM Campus Straubing; 2023.
53.
Boer D. SSVS-G. Deutsche Kurzskala des Wertefragebogens von SH Schwartz (Short Schwartz’s Value Survey). Handbuch Kurzskalen psychologischer Merkmale Berlin, Germany: Medizinisch-Wissenschaftlichen Verlagsgesellschaft. 2013.
54.
Field A. Discovering statistics using IBM SPSS statistics. 5 ed. sage; 2018.
55.
Schwartz SH. Value orientations: measurement, antecedents and consequences across nations. Measuring attitudes cross-nationally. Lessons from the European Social Survey. 2007;169:204.
56.
Primer AP. Quantitative methods in psychology. Psychol Bull. 1992;112(1):155–9.
57.
Backhaus K, Erichson B, Plinke W, Weiber R. Multivariate Analysemethoden: Eine anwendungsorientierte Einführung. Heidelberg: Springer-Verlag; 2006.
58.
Dehghan M, Ghanbari A, Heidari FG, Shahrbabaki PM, Zakeri MA. Use of complementary and alternative medicine in general population during COVID-19 outbreak: a survey in Iran. J Integr Med. 2022;20(1):45–51.PubMed
59.
Nguyen PH, Tran VD, Pham DT, Dao TNP, Dewey RS. Use of and attitudes towards herbal medicine during the COVID-19 pandemic: a cross-sectional study in Vietnam. Eur J Integr Med. 2021;44:101328.PubMedPubMedCentral
60.
Picking D, Younger N, Mitchell S, Delgoda R. The prevalence of herbal medicine home use and concomitant use with pharmaceutical medicines in Jamaica. J Ethnopharmacol. 2011;137(1):305–11.PubMed
61.
Welz AN, Emberger-Klein A, Menrad K. What motivates new, established and long-term users of herbal medicine: is there more than push and pull? BMC complementary and alternative medicine. 2019;19(1):1–9.
62.
Webster RK, Liu R, Karimullina K, Hall I, Amlot R, Rubin GJ. A systematic review of infectious illness presenteeism: prevalence, reasons and risk factors. BMC Public Health. 2019;19(1):1–13.
63.
Mittag O, Kotkas T, Reese C, Kampling H, Groskreutz H, de Boer W, et al. Intervention policies and social security in case of reduced working capacity in the Netherlands, Finland and Germany: a comparative analysis. Int J Public Health. 2018;63(9):1081–8.PubMed
64.
Gasmi A, Chirumbolo S, Peana M, Noor S, Menzel A, Dadar M, et al. The role of Diet and Supplementation of Natural Products in COVID-19 Prevention. Biol Trace Elem Res. 2022;200(1):27–30.PubMed
65.
Aldwihi LA, Khan SI, Alamri FF, AlRuthia Y, Alqahtani F, Fantoukh OI, et al. Patients’ behavior regarding dietary or herbal supplements before and during COVID-19 in Saudi Arabia. Int J Environ Res Public Health. 2021;18(10):5086.PubMedPubMedCentral
66.
Browne M, Thomson P, Rockloff MJ, Pennycook G. Going against the herd: psychological and cultural factors underlying the ‘vaccination confidence gap’. PLoS ONE. 2015;10(9):e0132562.PubMedPubMedCentral
67.
DiBonaventura Md, Chapman GB. Do decision biases predict bad decisions? Omission bias, naturalness bias, and influenza vaccination. Med Decis Making. 2008;28(4):532–9.PubMed
68.
Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine. 2020;38(42):6500–7.PubMedPubMedCentral
69.
Meier BP, Dillard AJ, Lappas CM. Predictors of the intention to receive a SARS-CoV-2 vaccine. J Public Health. 2022;44(3):713–5.
70.
Wardle J, Frawley J, Adams J, Sibbritt D, Steel A, Lauche R. Associations between complementary medicine utilization and influenza/pneumococcal vaccination: results of a national cross-sectional survey of 9151 australian women. Prev Med. 2017;105:184–9.PubMed
71.
Honda K, Jacobson JS. Use of complementary and alternative medicine among United States adults: the influences of personality, coping strategies, and social support. Prev Med. 2005;40(1):46–53.PubMed
72.
Sirois FM, Purc-Stephenson RJ. Personality and consultations with complementary and alternative medicine practitioners: a five-factor model investigation of the degree of use and motives. J Altern Complement Med. 2008;14(9):1151–8.PubMed
73.
Alotiby AA, Al-Harbi LN. Prevalence of using herbs and natural products as a protective measure during the COVID-19 pandemic among the saudi population: an online cross-sectional survey. Saudi Pharm J. 2021;29(5):410–7.
74.
Lam CS, Koon HK, Chung VC-H, Cheung YT. A public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong. PLoS ONE. 2021;16(7):e0253890.PubMedPubMedCentral
75.
Tanislav C, Kostev K. Fewer non-COVID-19 respiratory tract infections and gastrointestinal infections during the COVID-19 pandemic. J Med Virol. 2022;94(1):298–302.PubMed
76.
Ayosanmi OS, Alli BY, Akingbule OA, Alaga AH, Perepelkin J, Marjorie D, et al. Prevalence and correlates of Self-Medication Practices for Prevention and Treatment of COVID-19: a systematic review. Antibiotics. 2022;11(6):808.PubMedPubMedCentral
77.
Limaye D, Limaye V, Krause G, Fortwengel G. A systematic review of the literature to assess self-medication practices. Annals of Medical and Health Sciences Research; 2017.
78.
Kludacz-Alessandri M, Hawrysz L, Korneta P, Gierszewska G, Pomaranik W, Walczak R. The impact of medical teleconsultations on general practitioner-patient communication during COVID-19: a case study from Poland. PLoS ONE. 2021;16(7):e0254960.PubMedPubMedCentral
79.
Homeniuk R, Collins C. How COVID-19 has affected general practice consultations and income: general practitioner cross-sectional population survey evidence from Ireland. BMJ Open. 2021;11(4):e044685.PubMedCentral
80.
81.
Michalowsky B, Hoffmann W, Bohlken J, Kostev K. Effect of the COVID-19 lockdown on disease recognition and utilisation of healthcare services in the older population in Germany: a cross-sectional study. Age Ageing. 2020;50(2):317–25.PubMedCentral
82.
Malik M, Tahir MJ, Jabbar R, Ahmed A, Hussain R. Self-medication during Covid-19 pandemic: challenges and opportunities. Drugs & Therapy Perspectives. 2020;36(12):565–7.
83.
Suleiman A. Attitudes and beliefs of consumers of herbal medicines in Riyadh, Saudi Arabia. J Community Med Health Educ. 2014;4(2):269.
84.
Soboleva M, Loskutova E, Kosova I, Amelina I. Problems and the prospects of Pharmaceutical Consultation in the Drugstores. Arch Pharm Pract. 2020;11(2):154–9.
85.
Blackburn DF, Gill M, Krol E, Taylor J. Natural health products and community pharmacy—remove the mysticism not the product. J Pharm Pract. 2017;30(6):590–2.PubMed
86.
Farrell J, Ries NM, Boon H. Pharmacists and natural health products: a systematic analysis of professional responsibilities in Canada. Pharm Pract (Internet). 2008;6(1):33–42.
87.
Erku DA, Belachew SA, Abrha S, Sinnollareddy M, Thomas J, Steadman KJ, et al. When fear and misinformation go viral: pharmacists’ role in deterring medication misinformation during the ‘infodemic’ surrounding COVID-19. Res Social Administrative Pharm. 2021;17(1):1954–63.
88.
Brown LR, Williams AJ, Shaw K, Ozakinci G, van Beusekom MM. Information-seeking behaviours and uncertainty around accessing primary care in the changing landscape of the COVID-19 pandemic: a qualitative study. BJGP open. 2022;6(1).
89.
Yáñez JA, Chung SA, Román BR, Hernández-Yépez PJ, Garcia-Solorzano FO, Del-Aguila-Arcentales S, et al. Chapter 14 - Prescription, over-the-counter (OTC), herbal, and other treatments and preventive uses for COVID-19. In: Hadi Dehghani M, Karri RR, Roy S, editors. Environmental and Health Management of Novel Coronavirus Disease (COVID-19). Academic Press; 2021. pp. 379–416.
90.
Aspalter C. European and asian health care systems in comparative perspective. Health Care Systems in Europe and Asia. Routledge; 2012. pp. 167–90.
91.
Sharma R, Hazra J, Prajapati P. Knowledge and awareness of pharmacovigilance among ayurveda physicians in Himachal Pradesh. Anc Sci life. 2017;36(4):234.PubMedPubMedCentral
92.
Sharma R, Galib R, Prajapati P. Good pharmacovigilance practice: accountability of ayurvedic pharmaceutical companies. Anc Sci life. 2017;36(3):167.PubMedPubMedCentral
93.
Alyami HS, Orabi MA, Aldhabbah FM, Alturki HN, Aburas WI, Alfayez AI, et al. Knowledge about COVID-19 and beliefs about and use of herbal products during the COVID-19 pandemic: a cross-sectional study in Saudi Arabia. Saudi Pharm J. 2020;28(11):1326–32.PubMedPubMedCentral
94.
Kreuter MW, McClure SM. The role of culture in health communication. Annu Rev Public Health. 2004;25:439–55.PubMed
95.
Göritz AS, Moser K. Repräsentativität im online panel. der Markt. 2000;39:156–62.
96.
Karataş Y, Khan Z, Bilen Ç, Boz A, Özagil ESG, Abussuutoğlu AB, et al. Traditional and complementary medicine use and beliefs during COVID-19 outbreak: a cross-sectional survey among the general population in Turkey. Adv Integr Med. 2021;8(4):261–6.PubMedPubMedCentral
97.
Nsibirwa S, Anguzu G, Kamukama S, Ocama P, Nankya-Mutyoba J. Herbal medicine use among patients with viral and non-viral Hepatitis in Uganda: prevalence, patterns and related factors. BMC Complement Med Ther. 2020;20(1):1–11.
Metadata
Title
Usage of Natural Health Products (NHPs) for respiratory diseases: user characteristics and NHP-Consumption behavior during the Covid-19 pandemic in Germany
Authors
Miriam Wolf
Agnes Emberger-Klein
Klaus Menrad
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
COVID-19
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-04180-9

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue

Research

Evaluation of antioxidant, anti-inflammatory, anticancer activities and molecular docking of Moringa oleifera seed oil extract against experimental model of Ehrlich ascites carcinoma in Swiss female albino mice

Research

The efficacy and safety of Chinese herbal medicine Guizhi Fuling capsule combined with low dose mifepristone in the treatment of uterine fibroids: a systematic review and meta-analysis of 28 randomized controlled trials

Research

Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial

Research

Effects of dandelion root on rat heart function and oxidative status

Research

Therapeutic effects of resveratrol and Omega-3 in mice atherosclerosis: focus on histopathological changes

Research

Protective effects of GuanXinNing tablet (GXNT) on diabetic encephalopathy in zucker diabetic obesity (ZDF) rats